Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
2.200
+0.030 (1.38%)
At close: Aug 22, 2025, 4:00 PM
2.200
0.00 (0.00%)
After-hours: Aug 22, 2025, 6:42 PM EDT

Bone Biologics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Selling, General & Admin
2.142.092.522.091.020.48
Upgrade
Research & Development
2.152.136.911.580.080.34
Upgrade
Operating Expenses
4.294.229.433.671.10.83
Upgrade
Operating Income
-4.29-4.22-9.43-3.67-1.1-0.83
Upgrade
Interest Expense
----0.73-0.81-1
Upgrade
Interest & Investment Income
0.070.060---
Upgrade
Other Non Operating Income (Expenses)
0.010.050.892.91--
Upgrade
EBT Excluding Unusual Items
-4.22-4.11-8.53-1.48-1.91-1.82
Upgrade
Legal Settlements
---0.41---
Upgrade
Other Unusual Items
----0.3-
Upgrade
Pretax Income
-4.22-4.11-8.95-1.48-1.61-1.82
Upgrade
Income Tax Expense
-----0
Upgrade
Net Income
-4.22-4.11-8.95-1.48-1.61-1.82
Upgrade
Preferred Dividends & Other Adjustments
3.213.21----
Upgrade
Net Income to Common
-7.43-7.32-8.95-1.48-1.61-1.82
Upgrade
Shares Outstanding (Basic)
000---
Upgrade
Shares Outstanding (Diluted)
000---
Upgrade
Shares Change (YoY)
369.71%476.60%----
Upgrade
EPS (Basic)
-16.56-28.97-204.05---
Upgrade
EPS (Diluted)
-16.56-28.97-204.05---
Upgrade
Free Cash Flow
-3.31-4.12-9.56-3.57-1.23-0.43
Upgrade
Free Cash Flow Per Share
-7.38-16.31-217.89---
Upgrade
EBITDA
------0.82
Upgrade
D&A For EBITDA
-----0
Upgrade
EBIT
-4.29-4.22-9.43-3.67-1.1-0.83
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q